The findings suggest that an appropriate entry point for active surveillance for prostate cancer is confirmatory biopsy with MRI guidance and that normal confirmatory biopsy findings and a low prostate-specific antigen density may be associated with less risk of a pathologic disease upgrade compared with other results. Here, KLK3 is linked to Familial prostate cancer.